These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 30895608)

  • 1. Prelamin A overexpression promotes detrusor calcification/aging in urinary incontinence via prelamin A accumulation.
    Wu J; Guan F; Luo W; Yuan ZW; Chen RQ; Gou X; Shi X; Guo HX; Fang KW
    J Cell Physiol; 2019 Aug; 234(10):17800-17811. PubMed ID: 30895608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prelamin A acts to accelerate smooth muscle cell senescence and is a novel biomarker of human vascular aging.
    Ragnauth CD; Warren DT; Liu Y; McNair R; Tajsic T; Figg N; Shroff R; Skepper J; Shanahan CM
    Circulation; 2010 May; 121(20):2200-10. PubMed ID: 20458013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining substrate requirements for cleavage of farnesylated prelamin A by the integral membrane zinc metalloprotease ZMPSTE24.
    Wood KM; Spear ED; Mossberg OW; Odinammadu KO; Xu W; Michaelis S
    PLoS One; 2020; 15(12):e0239269. PubMed ID: 33315887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LMNA mutations resulting in lipodystrophy and HIV protease inhibitors trigger vascular smooth muscle cell senescence and calcification: Role of ZMPSTE24 downregulation.
    Afonso P; Auclair M; Boccara F; Vantyghem MC; Katlama C; Capeau J; Vigouroux C; Caron-Debarle M
    Atherosclerosis; 2016 Feb; 245():200-11. PubMed ID: 26724531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency in ZMPSTE24 and resulting farnesyl-prelamin A accumulation only modestly affect mouse adipose tissue stores.
    Heizer PJ; Yang Y; Tu Y; Kim PH; Chen NY; Hu Y; Yoshinaga Y; de Jong PJ; Vergnes L; Morales JE; Li RL; Jackson N; Reue K; Young SG; Fong LG
    J Lipid Res; 2020 Mar; 61(3):413-421. PubMed ID: 31941672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of protein geranylgeranyltransferase-I lead to prelamin A accumulation in cells by inhibiting ZMPSTE24.
    Chang SY; Hudon-Miller SE; Yang SH; Jung HJ; Lee JM; Farber E; Subramanian T; Andres DA; Spielmann HP; Hrycyna CA; Young SG; Fong LG
    J Lipid Res; 2012 Jun; 53(6):1176-82. PubMed ID: 22448028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prelamin A accelerates vascular calcification via activation of the DNA damage response and senescence-associated secretory phenotype in vascular smooth muscle cells.
    Liu Y; Drozdov I; Shroff R; Beltran LE; Shanahan CM
    Circ Res; 2013 May; 112(10):e99-109. PubMed ID: 23564641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs affecting prelamin A processing: effects on heterochromatin organization.
    Mattioli E; Columbaro M; Capanni C; Santi S; Maraldi NM; D'Apice MR; Novelli G; Riccio M; Squarzoni S; Foisner R; Lattanzi G
    Exp Cell Res; 2008 Feb; 314(3):453-62. PubMed ID: 18093584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking protein farnesyltransferase improves nuclear shape in fibroblasts from humans with progeroid syndromes.
    Toth JI; Yang SH; Qiao X; Beigneux AP; Gelb MH; Moulson CL; Miner JH; Young SG; Fong LG
    Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12873-8. PubMed ID: 16129834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A humanized yeast system to analyze cleavage of prelamin A by ZMPSTE24.
    Spear ED; Alford RF; Babatz TD; Wood KM; Mossberg OW; Odinammadu K; Shilagardi K; Gray JJ; Michaelis S
    Methods; 2019 Mar; 157():47-55. PubMed ID: 30625386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site specificity determinants for prelamin A cleavage by the zinc metalloprotease ZMPSTE24.
    Babatz TD; Spear ED; Xu W; Sun OL; Nie L; Carpenter EP; Michaelis S
    J Biol Chem; 2021; 296():100165. PubMed ID: 33293369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sustained accumulation of prelamin A and depletion of lamin A/C both cause oxidative stress and mitochondrial dysfunction but induce different cell fates.
    Sieprath T; Corne TD; Nooteboom M; Grootaert C; Rajkovic A; Buysschaert B; Robijns J; Broers JL; Ramaekers FC; Koopman WJ; Willems PH; De Vos WH
    Nucleus; 2015; 6(3):236-46. PubMed ID: 25996284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV protease inhibitors block the zinc metalloproteinase ZMPSTE24 and lead to an accumulation of prelamin A in cells.
    Coffinier C; Hudon SE; Farber EA; Chang SY; Hrycyna CA; Young SG; Fong LG
    Proc Natl Acad Sci U S A; 2007 Aug; 104(33):13432-7. PubMed ID: 17652517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prelamin A processing, accumulation and distribution in normal cells and laminopathy disorders.
    Casasola A; Scalzo D; Nandakumar V; Halow J; Recillas-Targa F; Groudine M; Rincón-Arano H
    Nucleus; 2016; 7(1):84-102. PubMed ID: 26900797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different prelamin A forms accumulate in human fibroblasts: a study in experimental models and progeria.
    Dominici S; Fiori V; Magnani M; Schena E; Capanni C; Camozzi D; D'Apice MR; Le Dour C; Auclair M; Caron M; Novelli G; Vigouroux C; Maraldi NM; Lattanzi G
    Eur J Histochem; 2009; 53(1):43-52. PubMed ID: 19351612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accumulation of prelamin A induces premature aging through mTOR overactivation.
    Pan X; Jiang B; Wu X; Xu H; Cao S; Bai N; Li X; Yi F; Guo Q; Guo W; Song X; Meng F; Li X; Liu Y; Cao L
    FASEB J; 2020 Jun; 34(6):7905-7914. PubMed ID: 32282093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prelamin A endoproteolytic processing in vitro by recombinant Zmpste24.
    Corrigan DP; Kuszczak D; Rusinol AE; Thewke DP; Hrycyna CA; Michaelis S; Sinensky MS
    Biochem J; 2005 Apr; 387(Pt 1):129-38. PubMed ID: 15479156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prelamin A farnesylation and progeroid syndromes.
    Young SG; Meta M; Yang SH; Fong LG
    J Biol Chem; 2006 Dec; 281(52):39741-5. PubMed ID: 17090536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prelamin A and lamin A appear to be dispensable in the nuclear lamina.
    Fong LG; Ng JK; Lammerding J; Vickers TA; Meta M; Coté N; Gavino B; Qiao X; Chang SY; Young SR; Yang SH; Stewart CL; Lee RT; Bennett CF; Bergo MO; Young SG
    J Clin Invest; 2006 Mar; 116(3):743-52. PubMed ID: 16511604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mutation abolishing the ZMPSTE24 cleavage site in prelamin A causes a progeroid disorder.
    Wang Y; Lichter-Konecki U; Anyane-Yeboa K; Shaw JE; Lu JT; Östlund C; Shin JY; Clark LN; Gundersen GG; Nagy PL; Worman HJ
    J Cell Sci; 2016 May; 129(10):1975-80. PubMed ID: 27034136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.